Rocky Mountain spotted fever

Lancet Infectious Diseases

Volumn 7, Issue 11, 2007, Pages 724-732

  Dantas Torres, Filipe ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; DIETHYLTOLUAMIDE; DOXYCYCLINE; TETRACYCLINE;

ANAMNESIS; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BRAZIL; BRONCHITIS; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DENGUE; DERMACENTOR; DIFFERENTIAL DIAGNOSIS; EHRLICHIOSIS; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; INFECTIOUS MONONUCLEOSIS; LEPTOSPIROSIS; MENINGOCOCCEMIA; PHYSICAL EXAMINATION; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RECOMMENDED DRUG DOSE; REVIEW; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SEPSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TICK BORNE DISEASE; TYPHOID FEVER; TYPHUS; UNITED STATES; VASCULITIS;

ANIMALS; DISEASE RESERVOIRS; HUMANS; NORTH AMERICA; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SOUTH AMERICA; TICKS;

EID: 35349019999     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70261-X     Document Type: Review

References (156)

1. Harrell G. Rocky Mountain spotted fever. Medicine (Baltimore) 28 (1949) 333-370
2. Walker D., and Fishbein D. Epidemiology of rickettsial diseases. Eur J Epidemiol 7 (1991) 237-245
3. Zavala-Castro J., Zavala-Velazquez J., Walker D., et al. Fatal human infection with Rickettsia rickettsii, Yucatan, Mexico. Emerg Infect Dis 12 (2006) 672-674
4. Dumler J., and Walker D. Rocky Mountain spotted fever-changing ecology and persisting virulence. N Engl J Med 353 (2005) 551-553
5. Kaplowitz L., Fischer J., and Sparling P. Rocky Mountain spotted fever: a clinical dilemma. Curr Clin Top Infect Dis 2 (1981) 89-108
6. Westerman E. Rocky Mountain spotless fever. A dilemma for the clinician. Arch Intern Med 142 (1982) 1106-1107
7. Masters E., Olson G., Weiner S., and Paddock C. Rocky Mountain spotted fever: a clinician's dilemma. Arch Intern Med 163 (2003) 769-774
8. Razzaq S., and Schutze G. Rocky Mountain spotted fever: a physician's challenge. Pediatr Rev 26 (2005) 125-130
9. Chapman A., Bakken J., Folk S., et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 55 (2006) 1-27
10. Maxey E. Some observations on the so-called spotted fever of Idaho. Med Sentinel 7 (1899) 433-438
11. Thorner A., Walker D., and Petri Jr. W. Rocky Mountain spotted fever. Clin Infect Dis 27 (1998) 1353-1359
12. Wilson L., and Chowning W. Studies in Pyroplasmosis hominis ("spotted fever" or "tick fever" of the Rocky Mountains). J Infect Dis 1 (1904) 31-57
13. King W. Experimental transmission of Rocky Mountain spotted fever by means of the tick. Preliminary note. Public Health Rep 21 (1906) 863-864
14. Ricketts H. The study of "Rocky Mountain spotted fever" (tick fever?) by means of animal inoculations. A preliminary communication. JAMA 47 (1906) 33-36
15. Ricketts H., and Gomez L. Studies on immunity in Rocky Mountain spotted fever: first communication. J Infect Dis 5 (1908) 221-244
16. Ricketts H. Some aspects of Rocky Mountain spotted fever as shown by recent investigations. Med Rec 76 (1909) 843-855
17. Parola P., Paddock C., and Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 18 (2005) 719-756
18. Le Count E. A contribution to the pathological anatomy of Rocky Mountain spotted fever. J Infect Dis 8 (1911) 421-426
19. Wolbach S. Studies on Rocky Mountain spotted fever. J Med Res 41 (1919) 2-197
20. Bengtson I. Classification of the Rickettsiae of Rocky Mountain spotted fever and of endemic (Murine) typhus. J Bacteriol 53 (1947) 325-327
21. Philip C. Rocky Mountain spotted fever. Bull Med Libr Assoc 29 (1940) 86-92
22. Harrell G., Venning W., and Wolff W. The treatment of Rocky Mountain spotted fever with particular reference to intravenous fluids: a new approach to basic supportive therapy. JAMA 126 (1944) 929-934
23. Topping N. Rocky Mountain spotted fever: further experience in the therapeutic use of immune rabbit serum. Public Health Rep 58 (1947) 757-775
24. Obijeski J., Palmer E., and Tzianabos T. Proteins of purified rickettsiae. Microbios 11 (1974) 61-76
25. Pedersen Jr. C., and Walters V. Comparative electrophoresis of spotted fever group rickettsial proteins. Life Sci 22 (1978) 583-587
26. Anacker R., List R., Mann R., Hayes S., and Thomas L. Characterization of monoclonal antibodies protecting mice against Rickettsia rickettsii. J Infect Dis 151 (1985) 1052-1060
27. 35S]methionine-radiolabeled proteins of Rickettsia conorii and Rickettsia rickettsii. J Infect Dis 154 (1986) 717-721
28. 125I-labeled proteins and detection of soluble antigens of Rickettsia rickettsii. Infect Immun 52 (1986) 120-127
29. Raoult D., and Roux V. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 10 (1997) 694-719
30. Silber J. Rocky Mountain spotted fever. Clin Dermatol 14 (1996) 245-258
31. Parola P., and Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 32 (2001) 897-928
32. Harrell G., and Aikawa J. Pathogenesis of circulatory failure in Rocky Mountain spotted fever. Arch Intern Med 83 (1949) 331-347
33. Walker D. Rocky Mountain spotted fever: a disease in need of microbiological concern. Clin Microbiol Rev 2 (1989) 227-240
34. Lacz N., Schwartz R., and Kapila R. Rocky Mountain spotted fever. J Eur Acad Dermatol Venereol 20 (2006) 411-417
35. Andersson S., Zomorodipour A., Andersson J., et al. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396 (1998) 133-140
36. Ogata H., Audic S., Renesto-Audiffren P., et al. Mechanisms of evolution in Rickettsia conorii and R prowazekii. Science 293 (2001) 2093-2098
37. McLeod M., Qin X., Karpathy S., et al. Complete genome sequence of Rickettsia typhi and comparison with sequences of other rickettsiae. J Bacteriol 186 (2004) 5842-5855
38. Renesto P., Ogata H., Audic S., Claverie J., and Raoult D. Some lessons from Rickettsia genomics. FEMS Microbiol Rev 29 (2005) 99-117
39. Azad A., and Beard C. Rickettsial pathogens and their arthropod vectors. Emerg Infect Dis 4 (1998) 179-186
40. Mariotte C., Bustamante M., and Varela G. Discovery of the Rhipicephalus sanguineus Latreille naturally infected with Rocky Mountain spotted fever in Sonora (Mexico) 1944. Rev Inst Salubr Enferm Trop 5 (1944) 297-300 (in Spanish).
41. Magnarelli L., Anderson J., Burgdorfer W., Philip R., and Chappell W. Spotted fever group rickettsiae in immature and adult ticks (Acari: Ixodidae) from a focus of Rocky Mountain spotted fever in Connecticut. Can J Microbiol 31 (1985) 1131-1135
42. Bischof R., and Rogers D. Serologic survey of select infectious diseases in coyotes and raccoons in Nebraska. J Wildl Dis 41 (2005) 787-791
43. Bozeman F., Shiral A., Humphries J., and Fuller H. Ecology of Rocky Mountain spotted fever. II. Natural infection of wild mammals and birds in Virginia and Maryland. Am J Trop Med Hyg 16 (1967) 48-59
44. Burgdorfer W., Newhouse V., Pickens E., and Lackman D. Ecology of Rocky Mountain spotted fever in western Montana. I. Isolation of Rickettsia rickettsii from wild mammals. Am J Hyg 76 (1962) 293-301
45. Bustamante M., and Varela IV G. Studies on spotted fever in Mexico: the role of Rhipicephalus sanguineus in the transmission of spotted fever in the Mexican republic. Rev Inst Salubr Enferm Trop 8 (1947) 139-141 (in Spanish).
46. Demma L., Traeger M., Nicholson W., et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 353 (2005) 587-594
47. Parker R., Philip C., and Jellison W. Rocky Mountain spotted fever. Potentialities of tick transmission in relation to geographical occurrence in the United States. Am J Trop Med Hyg 8 (1933) 341-379
48. Dantas-Torres F., Figueredo L., and Brandao-Filho S. Rhipicephalus sanguineus (Acari: Ixodidae), the brown dog tick, parasitizing humans in Brazil. Rev Soc Bras Med Trop 39 (2006) 64-67
49. Rodaniche E. Natural infection of the tick, Amblyomma cajennense with Rickettsia rickettsii in Panama. Am J Trop Med Hyg 2 (1953) 696-699
50. Dias E., and Martins A. Spotted fever in Brazil. A summary. Am J Trop Med Hyg 19 (1939) 103-108
51. Guedes E., Leite R., Prata M., Pacheco R., Walker D., and Labruna M. Detection of Rickettsia rickettsii in the tick Amblyomma cajennense in a new Brazilian spotted fever endemic area in the state of Minas Gerais. Mem Inst Oswaldo Cruz 100 (2005) 841-845
52. Pinter A., and Labruna M. Isolation of Rickettsia rickettsii and Rickettsia bellii in cell culture from the tick Amblyomma aureolatum in Brazil. Ann N Y Acad Sci 1078 (2006) 523-529
53. Davis G. Experimental transmission of the spotted fevers of the United States, Colombia, and Brazil by the argasid tick Ornithodoros parkeri. Public Health Rep 58 (1943) 1201-1208
54. Parker R., Bell J., Chalgren W., Thrailkill F., and McKee M. The recovery of strains of Rocky Mountain spotted fever and tularemia from ticks of the eastern United States. J Infect Dis 91 (1952) 231-237
55. McDade J., and Newhouse V. Natural history of Rickettsia rickettsii. Annu Rev Microbiol 40 (1986) 287-309
56. Labruna M., Whitworth T., Horta M., et al. Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of São Paulo, Brazil, where Brazilian spotted fever is endemic. J Clin Microbiol 42 (2004) 90-98
57. Labruna M., McBride J., Bouyer D., Camargo L., Camargo E., and Walker D. Molecular evidence for a spotted fever group Rickettsia species in the tick Amblyomma longirostre in Brazil. J Med Entomol 41 (2004) 533-537
58. Labruna M., Whitworth T., Bouyer D., et al. Rickettsia bellii and Rickettsia amblyommii in Amblyomma ticks from the State of Rondonia, Western Amazon, Brazil. J Med Entomol 41 (2004) 1073-1081
59. Medina-Sanchez A., Bouyer D., Alcantara-Rodriguez V., et al. Detection of a typhus group Rickettsia in Amblyomma ticks in the state of Nuevo Leon, Mexico. Ann N Y Acad Sci 1063 (2005) 327-332
60. Cardoso L., Freitas R., Mafra C., et al. Characterization of Rickettsia spp circulating in a silent peri-urban focus for Brazilian spotted fever in Caratinga, Minas Gerais, Brazil. Cad Saude Publica 22 (2006) 495-501 (in Portuguese).
61. Eremeeva M., Bosserman E., Demma L., Zambrano M., Blau D., and Dasch G. Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona. Appl Environ Microbiol 72 (2006) 5569-5577
62. Moore J. Time relationships of the wood-tick in the transmission of Rocky Mountain spotted fever. J Infect Dis 8 (1911) 339-347
63. Spencer R., and Parker R. Rocky Mountain spotted fever: infectivity of fasting and recently fed ticks. Public Health Rep 38 (1923) 333-339
64. Johnson J., and Kadull P. Rocky Mountain spotted fever acquired in a laboratory. N Engl J Med 277 (1967) 842-847
65. Wells G., Woodward T., Fiset P., and Hornick R. Rocky Mountain spotted fever caused by blood transfusion. JAMA 239 (1978) 2763-2765
66. McKiel J. The rodent and avian-borne diseases in Canada. Can J Public Health 51 (1950) 220-225
67. Bustamente M., and Varela G. A new rickettsiosis in Mexico. The existence of American spotted fever in the states of Sinoloa and Sonora. Rev Inst Salubr Enferm Trop 4 (1943) 189-210 (in Spanish).
68. Bustamente M., and Varela G. Distribution of rickettsioses in Mexico. Rev Inst Salubr Enferm Trop 8 (1947) 3-14 (in Spanish).
69. Rodaniche E., and Rodaniche A. Spotted fever in Panama: isolation of the etiologic agent from a fatal case. Am J Trop Med 30 (1950) 511-517
70. Fuentes L. First case of Rocky Mountain spotted fever in Costa Rica, Central America. Rev Latinoam Microbiol 21 (1979) 167-172 (in Spanish).
71. Ripoll C., Remondegui C., Ordonez G., et al. Evidence of rickettsial spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med Hyg 61 (1999) 350-354
72. Patino L., Afanador A., and Paul J. A spotted fever in Tobia, Colombia. Preliminary report. Am J Trop Med 17 (1937) 639-653
73. Centers for Disease Control. Rocky Mountain spotted fever-United States, 1990. MMWR Morb Mortal Wkly Rep 40 (1991) 451-453 459.
74. Treadwell T., Holman R., Clarke M., Krebs J., Paddock C., and Childs J. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 63 (2000) 21-26
75. Childs J., and Paddock C. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn?. Am J Trop Med Hyg 66 (2002) 450-457
76. Spach D., Liles W., Campbell G., Quick R., Anderson D., and Fritsche T. Tick-borne diseases in the United States. N Engl J Med 329 (1993) 936-947
77. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1996. MMWR Morb Mortal Wkly Rep 45 (1997) 1-87
78. Walker D. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health 19 (1998) 237-269
79. Jajosky R., Hall P., Adams D., et al. Summary of notifiable diseases-United States, 2004. MMWR Morb Mortal Wkly Rep 53 (2006) 1-79
80. McNabb S., Jajosky R., Hall-Baker P., et al. Summary of notifiable diseases-United States, 2005. MMWR Morb Mortal Wkly Rep 54 (2007) 1-92
81. Centers for Disease Control and Prevention. Table II. (Part 6) Provisional cases of selected notifiable diseases, United States, week ending December 30, 2006. http://wonder.cdc.gov/mmwr/mmwr_reps.asp?mmwr_table=2F&mmwr_year=200 6&mmwr_week=52 (accessed Sept 4, 2007).
82. McDade J. Evidence supporting the hypothesis that rickettsial virulence factors determine the severity of spotted fever and typhus group infections. Ann NY Acad Sci 590 (1991) 20-26
83. Dalton M., Clarke M., Holman R., et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 52 (1995) 405-413
84. Paddock C., Holman R., Krebs J., and Childs J. Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg 67 (2002) 349-354
85. Eremeeva M., Dasch G., and Silverman D. Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii. Clin Diagn Lab Immunol 8 (2001) 788-796
86. Ministério da Saúde, Secretaria de Vigilância em Saúde. Outbreak of Brazilian spotted fever in the municipality of Petrópolis-RJ (2005). http://portal.saude.gov.br/portal/arquivos/pdf/nota_maculosa_corrigida.p df (accessed Sept 5, 2007).
87. Holman R., Paddock C., Curns A., Krebs J., McQuiston J., and Childs J. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 184 (2001) 1437-1444
88. Walker D., Hawkins H., and Hudson P. Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 107 (1983) 121-125
89. Centers for Disease Control and Prevention. Fatal cases of Rocky Mountain spotted fever in family clusters-three states, 2003. MMWR Morb Mortal Wkly Rep 53 (2004) 407-410
90. Salgo M., Telzak E., Currie B., et al. A focus of Rocky Mountain spotted fever within New York City. N Engl J Med 318 (1988) 1345-1348
91. Hattwick M., O'Brien R., and Hanson B. Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Intern Med 84 (1976) 732-739
92. Helmick C., Bernard K., and D'Angelo L. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 150 (1984) 480-488
93. Wilfert C., MacCormack J., Kleeman D., et al. Epidemiology of Rocky Mountain spotted fever as determined by active surveillance. J Infect Dis 150 (1984) 469-479
94. Kirk J., Fine I., Sexton D., and Muchmore H. Rocky Mountain spotted fever: a clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore) 69 (1990) 35-45
95. Vianna N., and Hinman A. Rocky Mountain spotted fever on Long Island. Epidemiologic and clinical aspects. Am J Med 51 (1971) 725-730
96. Linnemann Jr. C., and Janson P. The clinical presentations of Rocky Mountain spotted fever. Comments on recognition and management based on a study of 63 patients. Clin Pediatr (Phila) 17 (1978) 673-679
97. Elston D. Rickettsial skin disease: uncommon presentations. Clin Dermatol 23 (2005) 541-544
98. Ramos-e-Silva M., and Pereira A. Life-threatening eruptions due to infectious agents. Clin Dermatol 23 (2005) 148-156
99. Kaufmann J., Zaenglein A., Kaul A., and Chang M. Fever and rash in a 3-year-old girl: Rocky Mountain spotted fever. Cutis 70 (2002) 165-168
100. Hayden A., and Marshall G. Rocky Mountain spotted fever at Koair Children's Hospital, 1990-2002. J Ky Med Assoc 102 (2004) 209-214
101. Myers S., and Sexton D. Dermatologic manifestations of arthropod-borne diseases. Infect Dis Clin North Am 8 (1994) 689-712
102. Kirkland K., Marcom P., Sexton D., Dumler J., and Walker D. Rocky Mountain spotted fever complicated by gangrene: report of six cases and review. Clin Infect Dis 16 (1993) 629-634
103. Green W., Walker D., and Cain B. Fatal viscerotropic Rocky Mountain spotted fever: report of a case diagnosed by immunofluorescence. Am J Med 64 (1978) 523-528
104. Sexton D., and Kaye K. Rocky Mountain spotted fever. Med Clin North Am 86 (2002) 351-360
105. Hughes C. Rocky Mountain "spotless" fever with an erythema migrans-like skin lesion. Clin Infect Dis 21 (1995) 1328-1329
106. Walker D., Gay R., and Valdes-Dapena M. The occurrence of eschars in Rocky Mountain spotted fever. J Am Acad Dermatol 4 (1981) 571-576
107. Walker D., Paletta C., and Cain B. Pathogenesis of myocarditis in Rocky Mountain spotted fever. Arch Pathol Lab Med 104 (1980) 171-174
108. Donohue J. Lower respiratory tract involvement in Rocky Mountain spotted fever. Arch Intern Med 140 (1980) 223-227
109. Walker D., and Mattern W. Acute renal failure in Rocky Mountain spotted fever. Arch Intern Med 139 (1979) 443-448
110. Bleck T. Central nervous system involvement in rickettsial diseases. Neurol Clin 17 (1999) 801-812
111. Massey E., Thames T., Coffey C., and Gallis H. Neurologic complications of Rocky Mountain spotted fever. South Med J 78 (1985) 1288-1290
112. Weber D., and Walker D. Rocky Mountain spotted fever. Infect Dis Clin North Am 5 (1991) 19-35
113. Vaphiades M. Rocky Mountain spotted fever as a cause of macular star figure. J Neuroophthalmol 23 (2003) 276-278
114. Sexton D., Gallis H., McRae J., and Cate T. Possible needle-associated Rocky Mountain spotted fever [letter]. N Engl J Med 292 (1975) 645
115. Krober M. Skeletal muscle involvement in Rocky Mountain spotted fever. South Med J 71 (1978) 1575-1576
116. Hattwick M., Retailliau H., O'Brien R., Slutzker M., Fontaine R., and Hanson B. Fatal Rocky Mountain spotted fever. JAMA 240 (1978) 1499-1503
117. Middleton D. Rocky Mountain spotted fever: gastrointestinal and laboratory manifestations. South Med J 71 (1978) 629-632
118. Davis A., and Bradford W. Abdominal pain resembling acute appendicitis in Rocky Mountain spotted fever. JAMA 247 (1982) 2811-2812
119. Jiminez J., Byrne W., Seibert J., and Euler A. Gastrointestinal symptoms in Rocky Mountain spotted fever. Histopathologic finding of ulcerative enteritis with vascular. Clin Pediatr (Phila) 21 (1982) 581-584
120. Walker D., Lesesne H., Varma V., and Thacker W. Rocky Mountain spotted fever mimicking acute cholecystitis. Arch Intern Med 145 (1985) 2194-2196
121. Walker D. Gastroenterology of Rocky Mountain spotted fever. Pract Gastroenterol 10 (1986) 25-39
122. Walker D., Henderson F., and Hutchins G. Rocky Mountain spotted fever: mimicry of appendicitis or acute surgical abdomen?. Am J Dis Child 140 (1986) 742-744
123. Horney L., and Walker D. Meningoencephalitis as a major manifestation of Rocky Mountain spotted fever. South Med J 81 (1988) 915-918
124. Kaplan J., and Schonberger L. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg 35 (1986) 840-844
125. Singh-Behl D., La Rosa S., and Tomecki K. Tick-borne infections. Dermatol Clin 21 (2003) 237-244
126. Procop G., Burchette Jr. J., Howell D., and Sexton D. Immunoperoxidase and immunofluorescent staining of Rickettsia rickettsii in skin biopsies. A comparative study. Arch Pathol Lab Med 121 (1997) 894-899
127. Kostman J. Laboratory diagnosis of rickettsial diseases. Clin Dermatol 14 (1996) 301-306
128. Walker D., Cain B., and Olmstead M. Laboratory diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsia in cutaneous lesions. Am J Clin Pathol 69 (1978) 619-623
129. Dumler J., Gage W., Pettis G., Azad A., and Kuhadja F. Rapid immunoperoxidase demonstration of Rickettsia rickettsii in fixed cutaneous specimens from patients with Rocky Mountain spotted fever. Am J Clin Pathol 93 (1990) 410-414
130. Paddock C., Greer P., Ferebee T., et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 179 (1999) 1469-1476
131. Tzianabos T., Anderson B., and McDade J. Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology. J Clin Microbiol 27 (1989) 2866-2868
132. Dumler J., and Walker D. Diagnostic tests for Rocky Mountain spotted fever and other rickettsial diseases. Dermatol Clin 12 (1994) 25-36
133. Sexton D., Kanj S., Wilson K., et al. The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. Am J Trop Med Hyg 50 (1994) 59-63
134. Eremeeva M., Dasch G., and Silverman D. Evaluation of a PCR assay for quantitation of Rickettsia rickettsii and closely related spotted fever group rickettsiae. J Clin Microbiol 41 (2003) 5466-5472
135. Bratton R., and Corey R. Tick-borne disease. Am Fam Physician 71 (2005) 2323-2330
136. McKinnon Jr. H., and Howard T. Evaluating the febrile patient with a rash. Am Fam Physician 62 (2000) 804-816
137. Cale D., and McCarthy M. Treatment of Rocky Mountain spotted fever in children. Ann Pharmacother 31 (1997) 492-494
138. Purvis J., and Edwards M. Doxycycline use for rickettsial disease in pediatric patients. Pediatr Infect Dis J 19 (2000) 871-874
139. Donovan B., Weber D., Rublein J., and Raasch R. Treatment of tick-borne diseases. Ann Pharmacother 36 (2002) 1590-1597
140. Grossman E., Walchek A., and Freedman H. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 47 (1971) 567-570
141. Lochary M., Lockhart P., and Williams Jr. W. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 17 (1998) 429-431
142. Herbert W., Seeds J., Koontz W., and Cefalo R. Rocky Mountain spotted fever in pregnancy: differential diagnosis and treatment. South Med J 75 (1982) 1063-1066
143. Markley K., Levine A., and Chan Y. Rocky Mountain spotted fever in pregnancy. Obstet Gynecol 91 (1998) 860
144. Stallings S. Rocky Mountain spotted fever and pregnancy: a case report and review of the literature. Obstet Gynecol Surv 56 (2001) 37-42
145. O'Reilly M., Paddock C., Elchos B., Goddard J., Childs J., and Currie M. Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002. Ann N Y Acad Sci 990 (2003) 295-301
146. Richards A. Rickettsial vaccines: the old and the new. Expert Rev Vaccines 3 (2004) 541-555
147. Wilson M. Prevention of tick-borne diseases. Med Clin North Am 86 (2002) 219-238
148. McGinley-Smith D., and Tsao S. Dermatoses from ticks. J Am Acad Dermatol 49 (2003) 363-392
149. Cupp E. Biology of ticks. Vet Clin North Am Small Anim Pract 21 (1991) 1-26
150. Krinsky W. Dermatoses associated with the bites of mites and ticks (Arthropoda: Acari). Int J Dermatol 22 (1983) 75-91
151. Kaplan L. Other spotted fevers. Clin Dermatol 14 (1996) 259-267
152. Abrahamian F. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children-West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. Ann Emerg Med 37 (2001) 537-540
153. Needham G. Evaluation of five popular methods for tick removal. Pediatrics 75 (1985) 997-1002
154. Gammons M., and Salam G. Tick removal. Am Fam Physician 66 (2002) 643-645
155. Lanschuetzer C., Wieser M., Laimer M., Emberger M., and Hintner H. Improving the removal of intact ticks. Australas J Dermatol 44 (2003) 301
156. Patterson J., Fitzwater J., and Connell J. Localized tick bite reaction. Cutis 24 (1979) 168-169 172.